0
Your cart

Your cart is empty

Browse All departments
  • All departments
Price
  • R1,000 - R2,500 (1)
  • R2,500 - R5,000 (3)
  • R5,000 - R10,000 (3)
  • -
Status
Brand

Showing 1 - 7 of 7 matches in All departments

Cancer Prevention (Hardcover, 2007 ed.): H.-J. Senn, U Kapp Cancer Prevention (Hardcover, 2007 ed.)
H.-J. Senn, U Kapp
R6,200 R4,881 Discovery Miles 48 810 Save R1,319 (21%) Ships in 10 - 15 working days

This volume contains the main proceedings of the fourth international conference on "Cancer Prevention 2006," which was held during February 16 18, 2006, in St. Gallen, Switzerland. Written by international experts in the field, the book comprises a comprehensive update on the most recent developments in the upsurging fields of molecular biology and cancer genetics and their interactions with clinical epidemiology and cancer prevention at various levels.

Tumor Prevention and Genetics III (Hardcover, 2005 ed.): H.-J. Senn, R. Morant Tumor Prevention and Genetics III (Hardcover, 2005 ed.)
H.-J. Senn, R. Morant
R7,737 R6,084 Discovery Miles 60 840 Save R1,653 (21%) Ships in 10 - 15 working days

Identification of cancer risk factors and potential prevention strategies have been some of the most important medical and research contributions to the improvement of public health in the past half-century (Steele 2003). Und- standing the role of lifestyle, exposure to endogenous factors and exogenous environmental factors, and individual genetic and epigenetic variability have contributed significantly to this effort. Cancer prevention strategies have been developed based on results of epidemiologic, preclinical, and clinical studies that have generated clues for identifying risk factors that may be modulated by changes in lifestyle, such as smoking cessation or dietary modification (Greenwald 2002a). In addition, significant progress in medical interventions involving chemoprevention-a pharmacological approach to intervention that aims to prevent, arrest, or reverse either the initiation phase of carcinogenesis or the progression of premalignant cells-is beg- ning to pay dividends in reducing risks associated with cancer. Emerging technologies, identification of biomarkers of risk, and advances in genetics research also are finding applications in chemoprevention research that p- mise to speed the acquisition of knowledge on the molecular and cellular - fects of chemopreventive agents. 2 Lifestyle Approaches Population studies from the 1950s through the early 1980s provided c- pelling evidence that modifiable lifestyle choices can either increase or - crease cancer risk. For example, several landmark epidemiologic studies in the 1950s showed a clear association between smoking and lung cancer (Wynder and Graham 1950; Levin et al. 1950). In 1964, the U. S.

Tumor Prevention and Genetics III (Paperback, 2005 ed.): H.-J. Senn, R. Morant Tumor Prevention and Genetics III (Paperback, 2005 ed.)
H.-J. Senn, R. Morant
R7,298 Discovery Miles 72 980 Ships in 7 - 11 working days

Identification of cancer risk factors and potential prevention strategies have been some of the most important medical and research contributions to the improvement of public health in the past half-century (Steele 2003). Und- standing the role of lifestyle, exposure to endogenous factors and exogenous environmental factors, and individual genetic and epigenetic variability have contributed significantly to this effort. Cancer prevention strategies have been developed based on results of epidemiologic, preclinical, and clinical studies that have generated clues for identifying risk factors that may be modulated by changes in lifestyle, such as smoking cessation or dietary modification (Greenwald 2002a). In addition, significant progress in medical interventions involving chemoprevention-a pharmacological approach to intervention that aims to prevent, arrest, or reverse either the initiation phase of carcinogenesis or the progression of premalignant cells-is beg- ning to pay dividends in reducing risks associated with cancer. Emerging technologies, identification of biomarkers of risk, and advances in genetics research also are finding applications in chemoprevention research that p- mise to speed the acquisition of knowledge on the molecular and cellular - fects of chemopreventive agents. 2 Lifestyle Approaches Population studies from the 1950s through the early 1980s provided c- pelling evidence that modifiable lifestyle choices can either increase or - crease cancer risk. For example, several landmark epidemiologic studies in the 1950s showed a clear association between smoking and lung cancer (Wynder and Graham 1950; Levin et al. 1950). In 1964, the U. S.

Perioperative Chemotherapy - Rationale, Risk and Results (Paperback, Softcover reprint of the original 1st ed. 1985): U.... Perioperative Chemotherapy - Rationale, Risk and Results (Paperback, Softcover reprint of the original 1st ed. 1985)
U. Metzger, F. Largiader, H.-J. Senn
R2,958 Discovery Miles 29 580 Ships in 7 - 11 working days

One reason for failure to cure solid tumors by surgery appears to be the impossibility of controlling metastases that are present but latent at the time of operation. This failure is a common clinical experience with aggressive neoplasms. but it is not always appreciated in tumors with longer survival times. e. g . breast and colon cancer. In addition. recent evidence indicates that after resection of a primary tumor micrometas tases from it might be enhanced by suppression of immune and reticu loendothelial functions of the host. Other factors, such as increase of coagulability and stress in the perioperative period, can also promote tumor growth. The development of new metastases might be facilitated by cells forced into the circulation during operative manipulations. Such events could be important for the outcome of treatment and it is suggested that preventive measures should be directed to this systemic component of solid tumors. Radical surgery can reduce the number of tumor cells to a subclinical 3 6 stage (10 to 10 cells) in which chemotherapy might be more effective than in advanced stages. Chemotherapy, on the other hand, might aggravate the surgical morbidity by influencing the wound healing pro cess, by decreasing the immune response, and/or by toxicity to the bone marrow and to the gastrointestinal tract, for example."

Chemoprevention of Cancer - A Clinical Update (Paperback, Softcover reprint of the original 1st ed. 1999): H.-J. Senn, Alberto... Chemoprevention of Cancer - A Clinical Update (Paperback, Softcover reprint of the original 1st ed. 1999)
H.-J. Senn, Alberto Costa, Craig Jordan
R3,335 Discovery Miles 33 350 Ships in 7 - 11 working days

Pharmacologic interventions to prevent the evolution of human cancers are still in its infancy, although a good number o- mostly controlled - clinical studies have been performed in the past two decades. However, regarding the partially stagnating therapeutic results of major epithelial cancer types such as breast-, lung-, colon- and ENT-cancer types, the problem of in terference with the evolution of disease at a preclinical level is an intriguing one, and the field seems to develop into one of the fastest growing domaines of modern oncology. This process is fa cilitated by the developments of molecular on co-genetics and the gowing existence of family cancer units, allowing to better identi fy and inform respective high risk groups, thus enabling re searchers and clinicians to more realistically target their chemo preventive efforts to the true populations at risk. On this changing background, the newly formed International Society of Cancer Chemoprevention (ISCaC) together with the Swiss Cancer League and the Interdisciplinary Oncology Center of St. Gallen/Switzerland organized an international Symposium in September 1997, inviting basic researchers, epidemiologists and clinical oncologists of related disciplines to discuss pertinent issues of experimental and clinical chemo- and bio-prevention in a scientific workshop.

Cancer Prevention (Paperback, Softcover reprint of hardcover 1st ed. 2007): H.-J. Senn, U Kapp Cancer Prevention (Paperback, Softcover reprint of hardcover 1st ed. 2007)
H.-J. Senn, U Kapp
R5,852 Discovery Miles 58 520 Ships in 7 - 11 working days

This volume contains the main proceedings of the fourth international conference on "Cancer Prevention 2006," which was held during February 16 18, 2006, in St. Gallen, Switzerland. Written by international experts in the field, the book comprises a comprehensive update on the most recent developments in the upsurging fields of molecular biology and cancer genetics and their interactions with clinical epidemiology and cancer prevention at various levels.

Therapie des Mammakarzinoms (German, Paperback): T. Buchner, D Urbanitz, J Van De Loo Therapie des Mammakarzinoms (German, Paperback)
T. Buchner, D Urbanitz, J Van De Loo; Contributions by K.W. Brunner, H.-P. Heilmann, …
R1,496 Discovery Miles 14 960 Out of stock

palliativem Anspruch - stiitzt sich stark auf die Ergebnisse vergleichender Therapiestudien mit Berucksichtigung der Krankheitsstadien und prognostischen Faktoren.

Free Delivery
Pinterest Twitter Facebook Google+
You may like...
Loot
Nadine Gordimer Paperback  (2)
R336 R283 Discovery Miles 2 830
Casio LW-200-7AV Watch with 10-Year…
R899 R765 Discovery Miles 7 650
Simply Child Hot Air Balloon Mobile…
R390 Discovery Miles 3 900
Loot
Nadine Gordimer Paperback  (2)
R336 R283 Discovery Miles 2 830
BANTING 7 Day Meal Plans - Vegetarian
Rita Venter, Natalie Lawson, … Paperback R375 R275 Discovery Miles 2 750
Happy Baby Organic Baby Food S2 Simple…
R38 R36 Discovery Miles 360
Swiss Mobile Gear Gellihug Switch Shell…
R199 Discovery Miles 1 990
Thys & Trix
Brendon Daniels, Leandie du Randt Bosch, … DVD R160 R98 Discovery Miles 980
Russell Hobbs Ideal Temperature Iron
 (4)
R999 R894 Discovery Miles 8 940
Kingsons Valentine Series Shoulder Bag…
 (2)
R427 Discovery Miles 4 270

 

Partners